Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy

Case-Based Discussion: Role of Genetic Testing in Advanced M1 CRPC & M1 CRPC Post-Docataxel Chemotherapy and End-of-Life Care Podcast (2020) Presented by Leonard Gomella, MD and Joshua Lang, MD This educational activity is supported by independent educational grants from: AbbVie Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc. CME Available: https://auau.auanet.org/node/30124